Virtual Reality During Intrathecal Pump Refills in Children

Not Applicable

Completed

• Conditions: Cerebral Palsy
• Interventions: Other: Intrathecal pump refill with Virtual Reality; Other: Intrathecal pump refill; Other: Intrathecal pump refill with distraction

• Registration Number: NCT04737668
• Lead Sponsor: Moens Maarten

Brief Summary

The aim of the current study is to explore the effect of virtual reality on pain in children who undergo an intrathecal pump refill compared to usual care and distraction.

Detailed Description

Virtual reality (VR) is a technological rehabilitation tool that allows the user to experience the interaction with a computer-generated environment. It may provide some advantages over conventional care: it allows the simulation of realistic environments and patients feel more motivated by this kind of virtual environment. VR constitutes an enriched environment with augmented multiple sensory feedbacks (auditory, visual, tactile VR enriched environment) that has already shown some efficiency in reducing chronic pain. There is mounting evidence from acute pain conditions, such as wound care, that VR could play a role as an additional treatment method to relieve pain A possible explanation for its mechanism of action is provided by "the gate-theory of attention". VR reduces the perception of pain by diverting attention away from the pain. Most children experience pain and fear when receiving a medical treatment; two feelings which are closely related and affecting one another. Moreover, children often describe procedures involving needles as the most stressful portion of the hospital experience. Children who have been implanted with an intrathecal baclofen (ITB) pump, need to come to the hospital for a refill approximately every 3 months, depending on the exact dose. During the refill, the physician places a needle directly into the reservoir to refill the pump. To alleviate the pain and fear with these refill procedures, it is hypothesized that VR could alleviate pain and make these refills more feasible. Therefore, the aim of this study is to evaluate whether VR is reducing pain during a refill procedure, in children receiving intrathecal drug delivery compared to usual care.

Study Timeline

• Study First Submitted: 2021-01-26
• Study First Submitted QC: 2021-02-01
• Study First Posted: 2021-02-04
• Study Start: 2021-02-10
• Primary Completion: 2022-01-26
• Study Completion: 2022-01-26
• Status Verified: 2022-03
• Last Update Submitted: 2022-03-17
• Last Update Posted: 2022-03-18

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 6

Inclusion Criteria

• Children with cerebral palsy between 8 and 16 years who have an implanted pump for intrathecal drug delivery
• Child and parents have been informed of the study procedures and have given written informed consent
• Child and parents willing to comply with study protocol
• Child and parents are able to speak Dutch/French (questionnaires)
• Cognitive and language functioning enabling communication between the physician/researcher and the child

Exclusion Criteria

• Children with susceptibility to motion sickness or cyber-sickness
• Children with susceptibility to claustrophobia
• History of seizures/epilepsia

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: CROSSOVER

Arm && Interventions

Group	Intervention	Description
Virtual Reality	Intrathecal pump refill with Virtual Reality	Children will play a commercially available VR game during pump refill
Usual care	Intrathecal pump refill	Pump refill will be performed as usual.
Distraction	Intrathecal pump refill with distraction	Children will watch a commercial 360° music video on YouTube during pump refill

Primary Outcome Measures

Name	Time	Method
Pain intensity	Through study completion, an average of 6 months.	Pain intensity will be assessed with the Wong-Baker FACES scale in children, parents, physician and researcher, to evaluate differences in the 3 conditions (usual refill, refill with VR and refill with distraction).

Secondary Outcome Measures

Name	Time	Method
Anxiety	Through study completion, an average of 6 months.	The Children's Anxiety Meter (CAM) will be used to measure anxiety. This scale will be filled in by children and parents.
Fear	Through study completion, an average of 6 months.	The degree of fear will be measured using the Child Fear Scale, based on reporting from the child and parent.
Statisfaction	Through study completion, an average of 6 months.	The statisfaction will be evaluated by two questions, scoring on a 5-point Likert agreement scale, by the children, parents and physician after the refill with VR and after the refill with distraction.
Procedural pain	Through study completion, an average of 6 months.	Procedural pain during refill is assessed with the Face, Legs, Activity, Cry, Consolability scale.
Adverse events	Through study completion, an average of 6 months.	The incidence of adverse events (nausea, vomiting, motion sickness, dizziness, seizure) will be evaluated after the refill with VR.

Trial Locations

Locations (1)

Universitair Ziekenhuis Brussel; 🇧🇪 Jette, Belgium